Other important side effects experienced by some patients include:
- heart attacks,
- chest pain, and
- abnormal heart beats.
GENERIC AVAILABLE: No
PREPARATIONS: Tablets: 150 and 500 mg.
STORAGE: Tablets should be stored at room temperature, 15 C to 30 C (59 F to 86 F).
DOSING: The recommended dose is 1250 mg/m2 twice daily, with the two doses approximately 12 hours apart. Tablets should be taken 30 minutes after eating. Capecitabine usually is prescribed in repeated cycles of 3-weeks, with the drug taken for two consecutive weeks followed by a week without drug. Some patients may need lower or delayed dosing if there are side effects.
DRUG INTERACTIONS: Capecitabine increases the blood thinning effect of warfarin (Coumadin) and may increase the risk of bleeding. Capecitabine also may increase blood levels of phenytoin (Dilantin, Dilantin-125), and the dose of phenytoin may need to be reduced.
PREGNANCY: Capecitabine can damage the fetus. It should not be taken by pregnant women.
NURSING MOTHERS: It is not known whether capecitabine is secreted into breast milk.
Medically reviewed by Eni Williams, PharmD
Reference: FDA Prescribing Information
Quick GuideBreast Cancer Diagnosis and Treatment
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Use the pill identifier tool on RxList.